Your browser doesn't support javascript.
loading
Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group.
Eichenauer, Dennis A; Fuchs, Michael; Pluetschow, Annette; Klimm, Beate; Halbsguth, Teresa; Böll, Boris; von Tresckow, Bastian; Nogová, Lucia; Borchmann, Peter; Engert, Andreas.
Affiliation
  • Eichenauer DA; First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
Blood ; 118(16): 4363-5, 2011 Oct 20.
Article in En | MEDLINE | ID: mdl-21828141
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Antibodies, Monoclonal, Murine-Derived / Antineoplastic Agents Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2011 Document type: Article Affiliation country: Germany Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Antibodies, Monoclonal, Murine-Derived / Antineoplastic Agents Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2011 Document type: Article Affiliation country: Germany Country of publication: United States